Skip to content

A Web-Based Multimedia Intervention for Head and Neck Cancer Patients

A Web-based Multimedia Intervention for Head and Neck Cancer Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02442336
Enrollment
80
Registered
2015-05-13
Start date
2012-06-15
Completion date
2020-11-18
Last updated
2021-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of the Head and Neck

Brief summary

The overall goal is to develop and examine the acceptability of a web-based (Internet) intervention program for patients with head and neck cancer who have recently completed radiation therapy.

Detailed description

The overall goal is to develop and examine the acceptability of a theory-guided, web-based multimedia intervention program for head and neck cancer patients who have recently completed radiation therapy. The effects of this intervention on patients' quality of life (QOL) will also be evaluated.

Interventions

BEHAVIORALMy Journey AHead

The intervention program will contain information and interactive activities around swallowing concerns, proper oral care, healthy eating and nutrition, speech issues, stress and coping with cancer, and pain management.

Sponsors

Fox Chase Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx * Are receiving or have completed radiation therapy within in the past 12 months

Exclusion criteria

* Inability to read and/or communicate in English * Head and neck cancers of non-squamous histology (e.g., adenoid cystic carcinoma, adenocarcinoma, sarcoma) * Blindness or severity of visual impairment that precludes one's ability to view images/text * Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Patient DistressUp to 6 weeksPsychological distress will be assessed using the Brief Symptom Inventory-18. The Brief Symptom Inventory-18 (BSI-18) is an 18-item scale widely used to measure psychological distress. The BSI-18 yields a total score (Global Severity Index), which is a measure of overall psychological distress. Raw scores are converted to t-scores (range 0-100) based on gender-specific normative data from cancer patient populations. A t-score of 50 is equal to the mean of the population. Higher scores represent greater levels of distress. The BSI-18 provides a clinical case-rule classifying respondents who have a t-score score ≥ 63 on the GSI as having clinically significant symptoms. Other studies have used a lower cutoff, with a GSI t-score ≥ 57 recommended as a cutoff for clinically significant symptoms in a study of cancer patients.

Countries

United States

Participant flow

Participants by arm

ArmCount
My Journey AHead
Participants were provided access to a web-base intervention that included several modules on oral care, stress and coping, nutrition, and pain management.
55
Total55

Withdrawals & dropouts

PeriodReasonFG000
Overall Study6 patients assisted with the intervention development only.6
Overall StudyLost to Follow-up11
Overall StudyOf the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.19

Baseline characteristics

CharacteristicMy Journey AHead
Age, Continuous61.1 Years
STANDARD_DEVIATION 9.76
Brief Symptom Inventory-1867.04 units on a scale
STANDARD_DEVIATION 4.123
Cancer Behavior Inventory (CBI-B)92.25 units on a scale
STANDARD_DEVIATION 12.7
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
6 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
49 Participants
Region of Enrollment
United States
55 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
41 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 55
other
Total, other adverse events
50 / 55
serious
Total, serious adverse events
0 / 55

Outcome results

Primary

Patient Distress

Psychological distress will be assessed using the Brief Symptom Inventory-18. The Brief Symptom Inventory-18 (BSI-18) is an 18-item scale widely used to measure psychological distress. The BSI-18 yields a total score (Global Severity Index), which is a measure of overall psychological distress. Raw scores are converted to t-scores (range 0-100) based on gender-specific normative data from cancer patient populations. A t-score of 50 is equal to the mean of the population. Higher scores represent greater levels of distress. The BSI-18 provides a clinical case-rule classifying respondents who have a t-score score ≥ 63 on the GSI as having clinically significant symptoms. Other studies have used a lower cutoff, with a GSI t-score ≥ 57 recommended as a cutoff for clinically significant symptoms in a study of cancer patients.

Time frame: Up to 6 weeks

ArmMeasureValue (MEAN)Dispersion
Web-Based InterventionPatient Distress66.16 units on a scaleStandard Deviation 4.77

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026